Latest Parotid Tumors Companies Update
Dec 2023Intuitive Surgical Launched their da Vinci® Xi robotic surgery system with improved dexterity and visualization capabilities, potentially enabling more precise and minimally invasive parotid tumor surgery.Partnered with leading academic centers to conduct training programs on robotic-assisted parotid surgery for better adoption and improved patient outcomes.
Elekta AB Received FDA approval for their Versa™ Halcyon™ radiotherapy system with integrated 4D dynamic tumor tracking technology, providing more accurate radiation therapy for parotid tumors.Collaborated with healthcare institutions to implement advanced radiotherapy technologies for precise tumor targeting and minimized damage to surrounding tissues.
Varian Medical Systems Introduced their HyperArc™ high-dose-rate brachytherapy system with improved dosimetry planning and treatment delivery for parotid tumors, offering a less invasive alternative to surgery in certain cases.Focused on developing innovative and patient-centric radiotherapy solutions for effective parotid tumor treatment.
Boston Scientific Corporation Launched their Sonata™ facial nerve monitoring system for use during parotid tumor surgeries, assisting surgeons in preserving facial nerve function and minimizing potential complications.Emphasized their commitment to providing tools and technologies that enhance surgical precision and improve patient quality of life after parotid tumor treatment.
Medtronic (UK) Introduced their Stealth™ navigation system with virtual reality (VR) capabilities for parotid tumor surgery planning and intraoperative guidance, allowing for more precise tumor resections.Partnered with medical technology startups to explore further integration of VR and artificial intelligence for advanced parotid tumor surgery planning and execution.List of Parotid Tumors Key Companies in the Market
- Eli Lilly & Co
- Bayer AG
- Merck & Co. Inc.
- Pfizer Inc.
- Bristol-Myers Squibb
- Janssen Global Services, LLC
- Hoffmann-La Roche Ltd
- Novartis AG